Advances in cellular reprogramming: from stem cells to printed tissues

Prof Hagan Bayley, University of Oxford & Dr Mark Kotter, Founder & CEO bit.bio

Haygan Bayley Webinar Video
A scalable technology platform capable of producing consistent batches of every human cell has the potential to unlock a new generation of medicine: it will enable research and drug discovery to move on from inappropriate models and work with the cells that actually are affected by human disease.


This webinar discusses

  1. Today’s challenges in CNS research, disease modelling and drug discovery: limited access to reliable human models.
  2. How a novel cellular reprogramming technology, opti-ox™, resolves the inconsistency of cellular reprogramming and enables the precise, consistent, and scalable production of human cells.
  3. The fabrication of synthetic, printed and hybrid materials, and their applications.


  • Prof Hagan Bayley | University of Oxford
  • Dr Mark Kotter | Founder & CEO bit.bio

Download resource

    Please complete the form below.

    Please confirm that we may add you to our mailing list, and send you our latest news and updates:
    Yes, please email me

    You can unsubscribe at any time by clicking the link in the footer of our emails. Privacy policy.

    This site is protected by reCAPTCHA and the Google Privacy Policy and Terms apply.

    Discover more resources